The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors

Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue and play important roles in disease processes. Among the biologic activities of chemokines is inhibition of proliferation of normal hematopoietic progenitors. However, chemokines that inhibit normal...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 95; no. 4; pp. 1506 - 1508
Main Authors Hromas, Robert, Cripe, Larry, Hangoc, Giao, Cooper, Scott, Broxmeyer, Hal E.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 15.02.2000
The Americain Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue and play important roles in disease processes. Among the biologic activities of chemokines is inhibition of proliferation of normal hematopoietic progenitors. However, chemokines that inhibit normal progenitors rarely inhibit proliferation of hematopoietic progenitors from patients with chronic myelogenous leukemia (CML). We and others recently cloned a subfamily of CC chemokines that share similar amino-terminal peptide sequences and a remarkable ability to chemoattract T cells. These chemokines, Exodus-1/LARC/MIP-3α, Exodus-2/SLC/6Ckine/TCA4, and Exodus-3/CKβ11/MIP-3β, were found to inhibit proliferation of normal human marrow progenitors. The study described here found that these chemokines also inhibited the proliferation of progenitors in every sample of marrow from patients with CML that was tested. This demonstration of consistent inhibition of CML progenitor proliferation makes the 3 Exodus chemokines unique among chemokines.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V95.4.1506.004k41_1506_1508